Cite
HARVARD Citation
Fradley, M. et al. (2018). Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma. British journal of haematology. pp. 271-275. [Online].